Page 2 - Renal Medicine News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Renal medicine. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Renal Medicine Today - Breaking & Trending Today

Calliditas Therapeutics to Present Data at ERA 2024 May 23

Calliditas Therapeutics to Present Data at ERA 2024 May 23
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Richard Philipson , Richard Lafayette , Jonathan Barratt , Shikha Wadhwani , Renal Medicine At Leicester University , Northwestern University , European Renal Association , Chief Medical Officer , Poster Presentation , Focused Oral Room , Clinical Markers , Iga Nephropathy , Renal Medicine , Full Prescribing , Primary Immunoglobulin , Ihr Portfolio ,

Can a Risk Score Predict Kidney Injury After Cisplatin?

Can a Risk Score Predict Kidney Injury After Cisplatin?
medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.

United States , Dana Farber Cancer Institute , New Haven , Joelm Topf , Yale Onco , Shruti Gupta , Shveta Motwani , Anushree Shirali , Yale School Of Medicine , Division Of Renal Medicine , Renal Medicine , Medscape Medical News , Medscape Medical , Kidney Disease , Improving Global Outcomes , Yale Onco Nephrology , Yale School ,

What Underlies Sex Differences in CKD Cardiovascular Risk?

Men with chronic kidney disease show higher muscle sympathetic nerve activity, suggesting clues to their continued higher cardiovascular risk vs women even in older age. ....

United States , Emory University School Of Medicine , Matiasg Zanuzzi , Division Of Renal Medicine , Department Of Medicine , American Journal , Renal Medicine , Emory University School , Medscape Medical ,

Jonathan Barratt, MD: Atacicept Could 'Transform How We Think About Treating IgA Nephropathy'

Barratt explained findings from the phase 2b ORIGIN trial of atacicept and how it compares to current standard therapies in IgAN and other agents in the pipeline. ....

Jonathan Barratt , University Of Leicester , Mayer Professor , Renal Medicine ,